Vicinitas Therapeutics
South San Francisco, United States · Founded 2022 · $65.0M raised
- Headquarters
- South San Francisco, California
- Employees
- 11–50
- Founded
- 2022
- Business Model
- B2B
- Website
- vicinitatx.com
- Total Funding
- $65.0M
- Last Round
- $65.0M Series AJul 2022
- Rounds
- 1
About
Vicinitas Therapeutics is a South San Francisco-based biotechnology company pioneering a novel class of small-molecule therapeutics called DUBTACs — Deubiquitinase Targeting Chimeras — that stabilize disease-relevant proteins. The company launched in 2022 with $65 million in funding from Deerfield Management and other life sciences investors.
Summary
Vicinitas Therapeutics is a Biotech company based in South San Francisco, United States, founded in 2022. It has raised $65.0M in total across 1 round, most recently a $65.0M Series A round in Jul 2022. Investors include Andreessen Horowitz, Deerfield Management and Droia Ventures.
Tech & App Stack
3 technologies & apps tracked
Create a free account to track companies, build lists, and unlock premium data like the full tech & app stack.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Funding History
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Specialty pharmaceutical company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...